Metrics as of 10/17/2026, 08:39 AM (Berlin time), refresh in progress.
Electromed Stock
Electromed, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- James L. Cunniff
- Employees
- 196
- Market cap
- $227 M
- IPO
- 13/08/2010
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with…
Electromed stock: price history
1D
-2.2%
1W
-1.0%
1M
+4.9%
6M
+5.2%
YTD
-5.8%
1Y
+12.8%
2Y
+19.2%
5Y
+149.5%
10Y
+510.7%
Next earnings date
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~37% stronger price swings than usual
Ask the agents about Electromed
Analyst assessment of Electromed
PRICE TARGET LOW
US$47.00
CONSENSUS
US$48.50
MEDIAN
US$48.50
PRICE TARGET HIGH
US$50.00
0
STRONG BUY
5
BUY
0
HOLD
0
SELL
0
STRONG SELL
5
TOTAL · Buy
As of: 26/08/2026
Electromed stock metrics
P/E
20.01
P/B
4.2
EV/EBITDA
13.52
RETURN ON EQUITY
6.3%
NET MARGIN
17.5%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
82.8%
FLOAT SHARES
6,860,650
AVG. DAILY VOLUME (30D)
88,064
Insider transactions (SEC)
Cunniff James L.
Nagel Bradley M.
Nagel Bradley M.
Nagel Bradley M.
Cunniff James L.
Institutional holders
Comparable stocks
Frequently asked questions about Electromed stock
What does Electromed do?
Electromed, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is James L. Cunniff, the company employs around 196 people.
The IPO was on 13/08/2010; the stock trades on AMEX under the ticker ELMD.
What do analysts say about Electromed stock?
5 analysts rate the stock, the consensus is Buy (as of 26/08/2026).
The average price target is US$48.50, ranging from US$47.00 to US$50.00, with a median of US$48.50.
This is an external assessment, not a statement by Market Jury.
When does Electromed report next?
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly 37% stronger than usual.
Does Electromed pay a dividend?
No, Electromed currently does not pay a dividend.
Which stocks are comparable to Electromed?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Electromed stock analyzed?
Clicking "Analyze stock" lets five strategies assess Electromed against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.